R&D Single Cell Omics & Target Discovery at AstraZeneca, academia
VP of Corporate Business Development,
ex. CEO of Diadem Research (Alzheimer's Dx)
and HRM (Cell Therapy).
Head of Bioinformatics Lonza,
Director of Functional Genomics GSK. GSK Scientific Lead for Open Targets. Expert in network biology for target identification.
Leader in machine learning and systems biology for drug discovery. Pioneered multi-omics subtyping of cancer at Berkley Lab and EPFL. Director of the Centre for Global Oncology, Institute of Cancer research, UK
Pioneered the use of synthetic lethality in cancer drug discovery and led the discovery of PARP inhibitors against HR deficient BRCA mutated cancers. Deputy Head of Institute of Cancer ResearchBreast Cancer Division. He is the Chief Scientific Advisor of Enedra.
Leading tumour evolution scientist. He heads t the UCL Cancer Genome Evolution Research Group and co-leads on bioinformatics in the CRUK-UCL Lung Cancer Centre of Excellence and TRACERx team.